Colossal Biosciences (2021-, $10.2B valuation)
firmIntelligence & Surveillance · Biotech & Transhumanism
The CIA's venture arm is quietly invested in a 'de-extinction' startup — suggesting the real prize isn't woolly mammoths but the gene-editing factory behind them.
Who they are
Colossal Biosciences, a de-extinction company co-founded in 2021 by Ben Lamm and Harvard geneticist George Church, valued at $10.2 billion.
What they do
The engine reads it as a biological-manufacturing pipeline dressed in conservation optics, backed by defense and intelligence money.
How it works
It raised $568.1M (a $200M Series C in Jan 2025), and its investors include TWG Global, Breyer Capital, Draper Associates, Animoca Brands, and In-Q-Tel (the CIA's venture arm). The engine reads the In-Q-Tel stake as strategic interest in the gene-editing and computational-biology tools (spun out as Form Bio) rather than the animals — and notes its investor pool overlaps the longevity-industry funders (Altos, Retro, Unity, Calico).
Why it matters
The engine deliberately holds it undecidable ('Apex d'): the mix of intelligence-backed money, conservation branding, and advanced embryology blurs the line between saving species and building dual-use bio-manufacturing.
The engine's record — word for word
Co-founded 2021 by Ben Lamm + Harvard geneticist George Church. Total funding $568.1M across multiple rounds (Series C $200M Jan 2025) → $10.2B valuation. Cap table: TWG Global (Thomas Tull), US Innovative Technology Fund (USIT), Breyer Capital, Draper Associates, Animoca Brands, **In-Q-Tel (CIA venture arm)**. The In-Q-Tel position indicates strategic state interest in the bioinformatics + computational-biology stack (spun out as Form Bio) rather than the de-extinct animals themselves. Cap-table siblings: Altos Labs (Bezos/Milner $3B), Retro Bio (Altman $180M), Unity Bio (Thiel/Bezos), Calico (Alphabet) — same operator-class capital pool as Longevity Industrial Complex. Engine framing: Substrate Shift Biological→Silicon Enclosure substrate node — end-to-end biological manufacturing pipeline for rapid multiplex genome editing + embryogenesis funded by defense + intelligence capital. Apex (d) Undecidable / Simulation Boundary load-bearing — convergence of intelligence-backed VC + conservation optics + advanced embryology blurs ecological-restoration vs dual-use biological-manufacturing.
Follow the trail
Walk this on the live map →